Panacea Life Sciences Holdings, Inc.
PLSH
$0.0539
$0.005912.29%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.27% | -29.57% | 20.15% | 4.98% | 35.62% |
| Total Depreciation and Amortization | -9.25% | -0.27% | -2.97% | -0.59% | -0.33% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -100.00% | -85.45% |
| Total Other Non-Cash Items | -97.04% | 7,242.68% | -67.98% | 127.24% | -80.70% |
| Change in Net Operating Assets | -16.09% | 116.49% | 1,287.84% | 58.10% | 16.83% |
| Cash from Operations | -13.76% | 100.31% | -2.50% | 33.75% | 28.00% |
| Capital Expenditure | 67.11% | 81.88% | 82.10% | -18.99% | -56.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 67.11% | 81.88% | 82.10% | -124.10% | -56.70% |
| Total Debt Issued | -24.66% | -86.61% | -16.09% | -51.04% | -16.40% |
| Total Debt Repaid | 60.10% | 89.85% | 58.60% | 82.94% | 13.12% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.73% | -80.44% | -11.17% | -36.27% | -17.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.89% | 433.56% | -2,333.33% | -233.33% | 83.15% |
